0000899243-19-025205.txt : 20191007
0000899243-19-025205.hdr.sgml : 20191007
20191007195303
ACCESSION NUMBER: 0000899243-19-025205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191007
FILED AS OF DATE: 20191007
DATE AS OF CHANGE: 20191007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HealthCap VII, L.P.
CENTRAL INDEX KEY: 0001645161
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141710
BUSINESS ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1000-1018
BUSINESS PHONE: 41 21 614 3500
MAIL ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1000-1018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HealthCap VII GP S.A.
CENTRAL INDEX KEY: 0001790047
STATE OF INCORPORATION: V7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141711
BUSINESS ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1006
BUSINESS PHONE: 41-21-614 35 00
MAIL ADDRESS:
STREET 1: 18 AVENUE D'OUCHY
CITY: CH 1006 LAUSANNE
STATE: V8
ZIP: 1006
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-07
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001645161
HealthCap VII, L.P.
C/O HEALTHCAP VII GP S.A.
18 AVENUE OF D'OUCHY
LAUSANNE
V8
CH-1006
SWITZERLAND
0
0
1
0
0001790047
HealthCap VII GP S.A.
C/O HEALTHCAP VII GP S.A.,
18 AVENUE OF D'OUCHY
LAUSANNE
V8
CH-1006
SWITZERLAND
0
0
1
0
Common Stock
2019-10-07
4
C
0
1661382
A
1671941
I
See footnote
Common Stock
2019-10-07
4
C
0
427496
A
2099437
I
See footnote
Common Stock
2019-10-07
4
P
0
266667
15.00
A
2366104
I
See footnote
Series B Convertible Preferred Stock
2019-10-07
4
C
0
1661382
D
Common Stock
1661382
0
I
See footnote
Series C Convertible Preferred Stock
2019-10-07
4
C
0
427496
D
Common Stock
427496
0
I
See footnote
Immediately prior the closing of the Issuer's initial public offering the shares of preferred stock automatically converted into shares of the common stock. Each share of preferred stock was convertible into shares of common stock at any time at the option of the holder and had no expiration date.
The securities are directly held by HealthCap VII L.P. (the "Fund"). HealthCap VII GP S.A. (the "General Partner") is the sole general partner of the Fund. The General Partner disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
/s/ HealthCap VII L.P., By: Louis Rambo, attorney-in-fact
2019-10-07
/s/ HealthCap VII GP S.A., By: Louis Rambo, attorney-in-fact
2019-10-07